Jeffrey Cheah School of Medicine and Health Sciences, Monash University, 47500 Bandar Sunway, Malaysia.
BMC Complement Altern Med. 2014 Oct 17;14:404. doi: 10.1186/1472-6882-14-404.
Although studies have shown that a large proportion of cancer patients use CAM, no study on CAM use amongst orthopaedic oncology patients has been published. Therefore, this study aims to determine the prevalence, characteristics and factors associated with CAM use amongst orthopaedic oncology patients.
All consecutive consenting patients/parents who presented at the Orthopaedic Oncology Clinic, University Malaya Medical Centre (1st January to 31st December 2013) were interviewed using a structured questionnaire.
Overall, one hundred sixty-eight of the 274 patients recruited (61.3%) had used CAM at some time during their current illness. The prevalence of CAM used was 68% (123/181) for patients with malignant tumours and 48.4% (45/93) for patients with benign tumours. The most popular CAMs were biological-based therapies (90.5%), followed by mind-body techniques (40.5%). The most frequently used biological therapies were mega/multivitamins (31%), snakehead (Chana striatus) (28%) and sea cucumber (Stichopus horrens) (18%); whereas prayers (31%) and holy water (13%) dominated the mind-body category. Common reasons for CAM use were to improve physical well-being (60.1%), try out everything that would help (59.5%) and to enhance wound-healing (39.3%). Independent predictors for CAM use in multivariate analysis were paediatric patients [OR 2.46; 95% CI 0.99-6.06; p = 0.05], malignant tumours [OR 1.90; 95% CI 1.12-3.25; p = 0.018] and patients who underwent surgery [OR 2.06; 95% CI 1.15-3.69; p = 0.015]. Majority patients started taking CAMs following suggestions from family members (53%) and friends (49%). Sixty-six percent of patients felt they actually benefitted from CAM and 83.3% were satisfied/very satisfied. Only 5 patients reported side-effects. Majority of CAM users planned to continue CAM use or recommend it to others. However, only 31.5% of patients disclosed their CAM usage to their doctors.
This survey revealed a high prevalence of CAM usage amongst orthopaedic oncology patients, with majority patients expressing satisfaction towards CAM. Oncologists should proactively ask patients about CAM to prevent potential adverse effects, as most patients do not share this information with them.
尽管研究表明,很大一部分癌症患者使用 CAM,但目前还没有关于骨科肿瘤患者使用 CAM 的研究。因此,本研究旨在确定骨科肿瘤患者使用 CAM 的流行率、特征和相关因素。
2013 年 1 月 1 日至 12 月 31 日,所有在马来亚大学医学中心骨科肿瘤诊所就诊的连续同意的患者/家长均使用结构化问卷进行访谈。
总体而言,274 名入组患者中有 168 名(61.3%)在当前疾病期间曾使用过 CAM。恶性肿瘤患者使用 CAM 的患病率为 68%(123/181),良性肿瘤患者为 48.4%(45/93)。最受欢迎的 CAM 是基于生物的疗法(90.5%),其次是身心技术(40.5%)。最常使用的生物疗法是大/多种维生素(31%)、蛇头(Chana striatus)(28%)和海参(Stichopus horrens)(18%);而祈祷(31%)和圣水(13%)则主导着身心类别。使用 CAM 的常见原因是改善身体健康(60.1%)、尝试一切可能有帮助的方法(59.5%)和促进伤口愈合(39.3%)。多变量分析的 CAM 使用的独立预测因子是儿科患者[OR 2.46;95%CI 0.99-6.06;p = 0.05]、恶性肿瘤[OR 1.90;95%CI 1.12-3.25;p = 0.018]和接受手术的患者[OR 2.06;95%CI 1.15-3.69;p = 0.015]。大多数患者开始服用 CAM 是因为家人(53%)和朋友(49%)的建议。66%的患者表示他们实际上从 CAM 中受益,83.3%的患者满意/非常满意。只有 5 名患者报告有副作用。大多数 CAM 用户计划继续使用 CAM 或向他人推荐,但只有 31.5%的患者向医生透露了他们的 CAM 使用情况。
本调查显示,骨科肿瘤患者中 CAM 的使用率很高,大多数患者对 CAM 表示满意。肿瘤学家应该主动询问患者关于 CAM 的情况,以防止潜在的不良反应,因为大多数患者不会与他们分享这些信息。